Stockreport

Zevra to Report 2024 Fourth Quarter and Full Year Financial Results

Zevra Therapeutics, Inc.  (ZVRA) 
PDF CELEBRATION, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing [Read more]